111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Down 45.1% in April

111, Inc. Sponsored ADR (NASDAQ:YI) was the target of a significant decline in short interest during the month of April. As of April 30th, there was short interest totaling 13,805 shares, a decline of 45.1% from the April 15th total of 25,129 shares. Based on an average daily trading volume, of 11,742 shares, the days-to-cover ratio is currently 1.2 days. Currently, 0.3% of the shares of the company are sold short.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 7th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

111 Price Performance

Shares of YI stock opened at $5.79 on Friday. The stock has a market cap of $50.89 million, a P/E ratio of -5.79 and a beta of 0.66. 111 has a one year low of $2.48 and a one year high of $11.17. The stock has a fifty day moving average price of $6.50 and a 200 day moving average price of $5.49.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.